The goals of COPD treatment include reducing symptoms, preventing and treating exacerbations, reducing deaths related to the disease 3, and changing the underlying nature of the disease (otherwise ...

While 87% of UK adults are aware of COPD, a recent survey revealed that ... they would wait a month or longer before seeking treatment for symptoms such as breathlessness or a persistent cough.

Working with the University of Oxford, scientists at KCL said the treatment is "more effective ... with asthma and 85 people with COPD die every day in the UK. Even if not deadly, asthma attacks ...

Companies are exploring alternative treatment pathways and have several novel classes of drugs for COPD in development (Table 1), including inhibitors of leukotriene B 4 receptors and chemokine ...

Dr Samantha Walker, from the charity Asthma + Lung UK, said the results were "great news". "But it’s appalling that this is the first new treatment for those suffering from asthma and COPD ...

Those key challenges impacting the care of respiratory diseases include delays in diagnosis due to the intermittent nature of ...

In the UK, someone has an asthma attack every 10 ... "This could be a game-changer for people with asthma and COPD. Treatment for asthma and COPD exacerbations have not changed in 50 years despite ...

New imaging techniques reveal real-time lung function improvements, offering a breakthrough in diagnosing and treating ...

AI will be used to analyse the data and help medical professionals identify trends and triggers that can result in COPD needing care, Professor Crooks said. This will allow the clinic to put ...

A large-scale trial of a new treatment it is hoped will help stop Covid-19 patients from developing severe illness has begun in the UK. The first ... pulmonary disease (COPD) often had low levels ...

A novel way of scanning lungs can demonstrate the impact of treatment on lung function in real ... led by researchers at ...

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...